
Theralizumab Biosimilar - Research Grade
Catalog Number | Pack Size | List Price* | Promo Price* | Quantity | |
---|---|---|---|---|---|
ICH5023-1MG | 1mg | 386,00 | 270,20 | Add | |
ICH5023-5MG | 5mg | 846,00 | 592,20 | Add | |
ICH5023-10MG | 10mg | 1'315,00 | 920,50 | Add | |
ICH5023-20MG | 20mg | 2'231,00 | 1'561,70 | Add | |
ICH5023-50MG | 50mg | 4'181,00 | 2'926,70 | Add | |
ICH5023-100MG | 100mg | 5'556,00 | 3'889,20 | Add |
* CHF, excl. 7.7% VAT and shipping costs
Product Description
Detects human CD28. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Theralizumab.
Category | Antibody |
Supplier | Ichorbio |
Application | FA |
Regulatory Status | RUO |
Species Specificity | Hu |
Isotype | IgG4 |
Crossreactivity | Hu |
Format | Sterile, preservative-free, solution in PBS. BSA and Azide free. |
Concentration | 5mg/ml |
Purity | >95% by SDS-PAGE |
Storage Conditions | This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
References | Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method |
Product Line | Biosimilar |
Tech. Data Sheet | View datasheet |
Link To Supplier | https://www.ichor.bio |
Material Safety Data Sheet | Download PDF |